Clinical Trial Update: A Phase II Clinical Study of Epigallocatechin-3-gallate in Patients With Esophageal Squamous Cancer [Phase 2]

View source ↗

Summary

This is a Phase II clinical trial listing for Epigallocatechin-3-gallate in patients with esophageal squamous cell carcinoma, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Drugs mentioned

• Epigallocatechin-3-Gallate (epigallocatechin-3-gallate)

Snippet

Sponsor: Shandong Cancer Hospital and Institute | Conditions: Esophageal Cancer, Dysphagia, Esophageal | Phase 2 | Status: RECRUITING